Literature DB >> 4986725

Microbioassay of antimicrobial agents.

H J Simon, E J Yin.   

Abstract

A previously described agar-diffusion technique for microbioassay of antimicrobial agents has been modified to increase sensitivity of the technique and to extend the range of antimicrobial agents to which it is applicable. This microtechnique requires only 0.02 ml of an unknown test sample for assay, and is capable of measuring minute concentrations of antibiotics in buffer, serum, and urine. In some cases, up to a 20-fold increase in sensitivity is gained relative to other published standardized methods and the error of this method is less than +/-5%. Buffer standard curves have been established for this technique, concurrently with serum standard curves, yielding information on antimicrobial serum-binding and demonstrating linearity of the data points compared to the estimated regression line for the microconcentration ranges covered by this technique. This microassay technique is particularly well suited for pediatric research and for other investigations where sample volumes are small and quantitative accuracy is desired. Dilution of clinical samples to attain concentrations falling with the range of this assay makes the technique readily adaptable and suitable for general clinical pharmacological studies. The microassay technique has been standardized in buffer solutions and in normal human serum pools for the following antimicrobials: ampicillin, methicillin, penicillin G, oxacillin, cloxacillin, dicloxacillin, cephaloglycin, cephalexin, cephaloridine, cephalothin, erythromycin, rifamycin amino methyl piperazine, kanamycin, neomycin, streptomycin, colistin, polymyxin B, doxycycline, minocycline, oxytetracycline, tetracycline, and chloramphenicol.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4986725      PMCID: PMC376740          DOI: 10.1128/am.19.4.573-579.1970

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  3 in total

1.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

2.  Outline of details for official microbiological assays of antibiotics.

Authors:  A Kirshbaum; B Arret
Journal:  J Pharm Sci       Date:  1967-04       Impact factor: 3.534

  3 in total
  81 in total

1.  Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.

Authors:  P Cottagnoud; F Acosta; M Cottagnoud; K Neftel; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

2.  Lung bacterial clearance in murine pneumococcal pneumonia.

Authors:  M J Ansfield; D E Woods; W G Johanson
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

3.  Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.

Authors:  D Rodoni; F Hänni; C M Gerber; M Cottagnoud; K Neftel; M G Täuber; P Cottagnoud
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

4.  Pharmacological evaluation of amikacin in neonates.

Authors:  J B Howard; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

5.  In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes.

Authors:  M O Frank; G W Sullivan; H T Carper; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

6.  Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae.

Authors:  Christina Kratzer; Wolfgang Graninger; Karin Macfelda; Astrid Buxbaum; Apostolos Georgopoulos
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

7.  Pharmacokinetics and bacteriological efficacy of N-formimidoyl thienamycin in experimental Escherichia coli meningitis.

Authors:  P Patamasucon; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

8.  BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.

Authors:  V Rodriguez-Cerrato; F Ghaffar; J Saavedra; I C Michelow; R D Hardy; J Iglehart; K Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.

Authors:  V Rodriguez-Cerrato; C C McCoig; I C Michelow; F Ghaffar; H S Jafri; R D Hardy; C Patel; K Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

10.  Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis.

Authors:  P Cottagnoud; M Cottagnoud; F Acosta; L Flatz; F Kühn; A Stucki; J Entenza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-14       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.